85
Participants
Start Date
Not specified
Study Completion Date
August 31, 2001
Nelfinavir mesylate
Nevirapine
Azithromycin
Beth Israel Med Ctr, New York
Bellevue Hosp / New York Univ Med Ctr, New York
St Vincent's Hosp / Mem Sloan-Kettering Cancer Ctr, New York
SUNY / Erie County Med Ctr at Buffalo, Buffalo
Univ of Rochester Medical Center, Rochester
Univ of Pennsylvania at Philadelphia, Philadelphia
Howard Univ, Washington D.C.
Julio Arroyo, West Columbia
Emory Univ, Atlanta
Univ of Alabama at Birmingham, Birmingham
Case Western Reserve Univ, Cleveland
Division of Inf Diseases/ Indiana Univ Hosp, Indianapolis
Northwestern Univ Med School, Chicago
Cook County Hosp, Chicago
Rush Presbyterian - Saint Luke's Med Ctr, Chicago
Univ of Texas Southwestern Med Ctr of Dallas, Dallas
Univ of Texas, Southwestern Med Ctr of Dallas, Dallas
Univ of Washington, Seattle
Univ of Miami School of Medicine, Miami
Ohio State Univ Hosp Clinic, Columbus
Univ of Cincinnati, Cincinnati
Indiana Univ Hosp, Indianapolis
Univ of Texas Galveston, Galveston
Univ of Southern California / LA County USC Med Ctr, Los Angeles
Univ of California / San Diego Treatment Ctr, San Diego
Stanford Univ Med Ctr, Stanford
National Institute of Allergy and Infectious Diseases (NIAID)
NIH